NOVEL FORMULATION OF CT-P13 FOR SUBCUTANEOUS ADMINISTRATION IN PATIENTS WITH RHEUMATOID ARTHRITIS: INITIAL RESULTS FROM A PHASE I/III RANDOMISED CONTROLLED TRIAL

Category Primary study
JournalANNALS OF THE RHEUMATIC DISEASES
Year 2018
This article has no abstract
Epistemonikos ID: 93831ae8b0f0dbd663659cd4754bb421a0bf09a3
First added on: Mar 24, 2022